Department of Medicine Division of Cardiology, Wayne State University/Detroit Medical Center, Detroit, Michigan.
ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.
Catheter Cardiovasc Interv. 2019 Aug 1;94(2):264-273. doi: 10.1002/ccd.28025. Epub 2018 Dec 10.
To assess the efficacy and safety of transradial (TR) versus transfemoral (TF) percutaneous coronary intervention (PCI) in left main (LM) lesion.
TR-PCI is the preferred approach compared with TF approach because of less bleeding risk. LM-PCI is often challenging because of the anatomical complexity and uniqueness of supplying a large myocardium territory. We performed a systematic review and meta-analysis to assess the safety and efficacy of TR-PCI compared with TF-PCI of the LM lesions.
A comprehensive literature search of PUBMED, EMBASE, and Cochrane database was conducted to identify studies that reported the comparable outcomes between both approaches. Odds ratio (OR) and 95% confidence interval (CI) was calculated using the Mantel-Haenszel method.
A total of eight studies were included in the quantitative meta-analysis. TR-PCI resulted in lower bleeding risk (OR 0.31, 95%CI 0.18-0.52, P < 0.01, I = 0%) while maintaining similar procedural success rate, target lesion revascularization, myocardial infarction, stent thrombosis, and all-cause mortality during the study follow-up period.
TR-PCI may achieve similar efficacy with decreased bleeding risk compared to TF-PCI in LM lesions. When operator experience and anatomical complexity are favorable, TR approach is an attractive alternative access over TF approach in LM-PCI.
评估经桡动脉(TR)与经股动脉(TF)经皮冠状动脉介入治疗(PCI)在左主干(LM)病变中的疗效和安全性。
与 TF 入路相比,TR-PCI 出血风险较低,因此是首选方法。LM-PCI 通常具有挑战性,因为其解剖结构复杂,供应大面积心肌的独特性。我们进行了一项系统评价和荟萃分析,以评估与 TF-PCI 相比,TR-PCI 在 LM 病变中的安全性和疗效。
对 PUBMED、EMBASE 和 Cochrane 数据库进行全面文献检索,以确定报告两种方法可比结果的研究。使用 Mantel-Haenszel 方法计算比值比(OR)和 95%置信区间(CI)。
共有 8 项研究纳入定量荟萃分析。TR-PCI 可降低出血风险(OR 0.31,95%CI 0.18-0.52,P<0.01,I=0%),同时在研究随访期间保持相似的手术成功率、靶病变血运重建、心肌梗死、支架血栓形成和全因死亡率。
与 TF-PCI 相比,TR-PCI 治疗 LM 病变可能具有相似的疗效,同时出血风险降低。当术者经验和解剖结构复杂时,TR 入路是 LM-PCI 中替代 TF 入路的一种有吸引力的选择。